Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Blue Cross Proposes Fix for Uninsured Americans
Link ID 2658
Title Blue Cross Proposes Fix for Uninsured Americans
Url http://www.medscape.com/viewarticle/569150?src=rss
Description A U.S. health insurance giant on Wednesday presented a proposal to reduce the number of Americans without medical coverage and said it was intended as a blueprint for U.S. policymakers. Reuters Health Information
Category Articles > Business of Medicine
Keywords
Date Jan 24, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Business of Medicine
1. CMS Moves to Halt Medicare Reimbursement of CT Angiography, Except in Clinical Trials
  Open public comment for the proposed national coverage determination ends this weekend. Imaging societies are urging their members to voice their concerns, but acknowledge it may be too little, too late. Heartwire
Category:   Articles > Business of Medicine


2. UK Insurers Extend Freeze on Genetic Testing
  British insurers have agreed to extend a freeze on genetic tests to 2014, allowing consumers to continue taking out cover without disclosing the adverse results of tests to predict a predisposition to cancer or heart disease. Reuters Health Information
Category:   Articles > Business of Medicine


3. Promising Percutaneous Corevalve Data From Europe Leaves US Trialists Itching for Green Light From F
  New data from 18 European countries on the fully percutaneous aortic valve speak to low 30-day mortality and improved valve function sustained over the longer term. So why the holdup in the US, where nary a feasibility study has been conducted? Heartwire
Category:   Articles > Business of Medicine


4. Ex-UnitedHealth CEO to Pay $30 Mln to Settle Suit
  William McGuire, former chief of UnitedHealth Group Inc, has agreed to pay $30 million to settle a shareholder lawsuit accusing him of improperly manipulating stock-options awards, according to terms of a pact announced on Wednesday. Reuters Health Information
Category:   Articles > Business of Medicine


5. Why the NIH Trial to Assess Chelation Therapy (TACT) Should Be Abandoned
  The $30 million, NIH Phase 3 Trial to Assess Chelation Therapy (TACT) exposes subjects to a risky method that is known to be ineffective. The TACT should be abandoned and its origins investigated.
The Medscape Journal of Medicine
Category:   Articles > Business of Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS